T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BWLD
1251
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $12M | ﹤0.01% |
86,059
-4,291
| -5% | -$608K |
|
|
CGI
1252
DELISTED
Celadon Group Inc
CGI
| $11.9M | ﹤0.01% |
1,456,880
+8,920
| +0.6% | +$86.6K |
|
|
BLOX
1253
DELISTED
Infoblox Inc
BLOX
| $11.8M | ﹤0.01% |
630,840
-4,880
| -0.8% | -$84.6K |
|
1254
Avery Dennison
AVY
$13.6B
| $11.8M | ﹤0.01% |
157,321
-403,073
| -72% | -$29.9M |
|
|
INST
1255
DELISTED
Instructure, Inc.
INST
| $11.7M | ﹤0.01% |
617,470
+400
| +0.1% | +$7.38K |
|
1256
Polaris
PII
$3.91B
| $11.6M | ﹤0.01% |
142,285
+2,381
| +2% | +$211K |
|
1257
Avis
CAR
$4.84B
| $11.6M | ﹤0.01% |
359,192
-13,523
| -4% | -$374K |
|
|
ASRT
1258
DELISTED
Assertio
ASRT
| $11.6M | ﹤0.01% |
9,825
+9,316
| +1,830% | +$10.2M |
|
|
TE
1259
DELISTED
TECO ENERGY INC
TE
| $11.5M | ﹤0.01% |
416,085
-4,300
| -1% | -$119K |
|
|
WIBC
1260
DELISTED
WILSHIRE BANCORP INC
WIBC
| $11.3M | ﹤0.01% |
1,086,850
+340,130
| +46% | +$3.66M |
|
|
KW
1261
DELISTED
Kennedy-Wilson Holdings
KW
| $11.3M | ﹤0.01% |
596,383
+29,700
| +5% | +$615K |
|
1262
Hain Celestial
HAIN
$53.9M
| $11.3M | ﹤0.01% |
226,417
-17,490
| -7% | -$810K |
|
1263
Jacobs Solutions
J
$16.8B
| $11.2M | ﹤0.01% |
272,989
-2,418
| -0.9% | -$95.3K |
|
|
PR
1264
Permian Resources
PR
$17.7B
| $11.2M | ﹤0.01% |
+1,125,189
| New | +$11.3M |
|
|
SHOR
1265
DELISTED
ShoreTel, Inc.
SHOR
| $11.1M | ﹤0.01% |
1,664,682
+135,200
| +9% | +$896K |
|
1266
Patrick Industries
PATK
$2.78B
| $11.1M | ﹤0.01% |
414,878
+180,788
| +77% | +$4.04M |
|
|
GRA
1267
DELISTED
W.R. Grace & Co.
GRA
| $11M | ﹤0.01% |
149,663
+7,327
| +5% | +$560K |
|
1268
Xencor
XNCR
$1.71B
| $10.9M | ﹤0.01% |
575,316
-1,200
| -0.2% | -$16.5K |
|
1269
Generac Holdings
GNRC
$12.8B
| $10.9M | ﹤0.01% |
310,855
-3,910
| -1% | -$144K |
|
|
CLCD
1270
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $10.8M | ﹤0.01% |
1,327,315
-800
| -0.1% | -$5.37K |
|
|
AJRD
1271
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $10.8M | ﹤0.01% |
591,396
+30,286
| +5% | +$526K |
|
1272
Crawford & Co Class A
CRD.A
$632M
| $10.8M | ﹤0.01% |
1,415,427
+66,100
| +5% | +$446K |
|
1273
OSI Systems
OSIS
$3.77B
| $10.8M | ﹤0.01% |
185,688
-4,150
| -2% | -$229K |
|
1274
Essent Group
ESNT
$6.23B
| $10.8M | ﹤0.01% |
494,473
+893
| +0.2% | +$18.6K |
|
1275
REX American Resources
REX
$1.44B
| $10.7M | ﹤0.01% |
1,072,200
+1,800
| +0.2% | +$16.7K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.